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The Journal of Immunology
Podocytes Regulate Neutrophil Recruitment by Glomerular
Endothelial Cells via IL-6–Mediated Crosstalk
Sahithi J. Kuravi,*,1 Helen M. McGettrick,†,1 Simon C. Satchell,‡ Moin A. Saleem,‡
Lorraine Harper,* Julie M. Williams,x George Ed Rainger,{ and Caroline O. S. Savage†,2
Stromal cells actively modulate the inflammatory process, in part by influencing the ability of neighboring endothelial cells to sup-
port the recruitment of circulating leukocytes. We hypothesized that podocytes influence the ability of glomerular endothelial cells
(GEnCs) to recruit neutrophils during inflammation. To address this, human podocytes and human GEnCs were cultured on op-
posite sides of porous inserts and then treated with or without increasing concentrations of TNF-a prior to addition of neutrophils.
The presence of podocytes significantly reduced neutrophil recruitment to GEnCs by up to 50% when cultures were treated with
high-dose TNF-a (100 U/ml), when compared with GEnC monocultures. Importantly, this phenomenon was dependent on para-
crine actions of soluble IL-6, predominantly released by podocytes. A similar response was absent when HUVECs were cocultured
with podocytes, indicating a tissue-specific phenomenon. Suppressor of cytokine signaling 3 elicited the immunosuppressive
actions of IL-6 in a process that disrupted the presentation of chemokines on GEnCs by altering the expression of the duffy
Ag receptor for chemokines. Interestingly, suppressor of cytokine signaling 3 knockdown in GEnCs upregulated duffy Ag receptor
for chemokines and CXCL5 expression, thereby restoring the neutrophil recruitment. In summary, these studies reveal that
podocytes can negatively regulate neutrophil recruitment to inflamed GEnCs by modulating IL-6 signaling, identifying a potential
novel anti-inflammatory role of IL-6 in renal glomeruli. The Journal of Immunology, 2014, 193: 000–000.
R
ecruitment of circulating leukocytes is required for im-
mune surveillance and protective inflammatory responses
to microbial infection and tissue damage. In response to
inflammatory cytokines, endothelial cells (EnCs) upregulate ad-
hesion molecules (selectins, VCAM-1, and ICAM-1), which cap-
ture flowing leukocytes. They also present chemokines and lipid
signals that are necessary to stabilize adhesion and support onward
migration (reviewed in Ref. 1). Deregulation of these processes is
associated with the uncontrolled persistent infiltration of leuko-
cytes into inflamed tissues that underpins chronic inflammatory
diseases, as seen in vasculitic glomerulonephritis. For example,
excessive neutrophil binding in the highly specialized glomerular
capillary compartment is particularly evident during early neph-
ritogenic immune responses (2–7). The mechanisms involved in
neutrophil recruitment to glomerular EnCs (GEnCs) are well doc-
umented (4–10); however, much less is known about how these
mechanisms are influenced by stromal cells within the underlying
tissue.
We and others have previously shown that stromal cells, such as
fibroblasts, tissue-resident leukocytes, or smooth muscle cells,
influence the ability of neighboring EnCs to recruit leukocytes in
response to cytokine stimulation (reviewed in Ref. 11). Stromal
modulation of endothelial responses may occur via paracrine
signaling and alteration of junctional molecule complexes (12–16).
Similarly, in glomerular capillaries, neighboring glomerular epi-
thelial cells (podocytes) may be important in regulating different
physiological functions. A symbiotic paracrine communication
between GEnCs and podocytes via soluble mediators is recog-
nized during normal maintenance functions such as repair and
regeneration of lost or damaged GEnCs (17–26). For example,
vascular endothelial growth factor and angiopoietin-1, secreted by
podocytes, bind to their cognate receptors on GEnCs and mediate
crosstalk during angiogenesis (27–29). Moreover, a very recent
study also highlighted the involvement of crosstalk between
podocytes and endothelial cells in the production of glomerular
extracellular matrix (30). The present studies focused on further
identifying the intricate communication pathways between GEnCs
and podocytes that regulate leukocyte recruitment and trafficking
during inflammation.
IL-6 is secreted by different cells, including podocytes, and is
a vital modulator of immune and inflammatory responses (31–35).
IL-6 has been shown to act in a proinflammatory as well as anti-
inflammatory manner, and it is thought to act as an immunological
switch (36). In IL-6–deficient mice, aerosol exposure to endotoxin
induced neutrophilia in the lungs and markedly higher levels of
TNF-a and MIP-2 (CXCL2), suggesting that IL-6 can reduce
inflammatory responses (37). IL-6 signal transduction occurs via
*Centre for Translational Inflammation Research, School of Immunity and Infection,
University of Birmingham, Birmingham B15 2TT, United Kingdom; †School of
Immunity and Infection, College of Medical and Dental Sciences, University of
Birmingham, Birmingham B15 2TT, United Kingdom; ‡Academic Renal Unit,
Southmead Hospital, Bristol BS10 5NB, United Kingdom; xWellcome Trust Clinical
Research Facility, University Hospital Birmingham Foundation Trust, Birmingham
B15 2TH, United Kingdom; and {Clinical and Experimental Medicine, College of
Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT,
United Kingdom
1S.J.K. and H.M.M. are joint first authors.
2Current address: Discovery Medicine, Mechanistic Medicine Discovery Performance
Unit, GlaxoSmithKline, Stevenage, U.K.
Received for publication January 23, 2013. Accepted for publication April 21, 2014.
This work was supported by Medical Research Council Grant RRAK 12708.
Address correspondence and reprint requests to Dr. Sahithi Jyothsna Kuravi, Renal
Immunobiology, Centre for Translational Inflammation Research, University of
Birmingham Research Laboratories, Birmingham B15 2WD, U.K. E-mail address:
s.j.panchagnula@bham.ac.uk
The online version of this article contains supplemental material.
Abbreviations used in this article: DARC, duffy Ag receptor for chemokines; EnC,
endothelial cell; GEnC, glomerular endothelial cell; SOCS, suppressor of cytokine
signaling.
This is an open-access article distributed under the terms of the CC-BY 3.0 Unported
license.
Copyright  2014 The Authors 0022-1767/14
www.jimmunol.org/cgi/doi/10.4049/jimmunol.1300229













the JAK/STAT pathway (38, 39), whereas negative regulation is
mediated by the expression of suppressor of cytokine signaling
(SOCS) 3 (40). Thus, the autocrine and paracrine actions of IL-6
released by podocytes in glomeruli need further investigation.
In this study, we investigated the ability to modulate the TNF-a–
induced neutrophil recruitment to cocultured GEnCs using an
established in vitro model system (41). We identified soluble IL-6
as key inhibitor of neutrophil recruitment in glomerular cocultures
and investigated the mechanisms that are involved in resolution of
inflammation in GEnC/podocyte cocultures. Understanding these
pathways is of physiological relevance given the increasing avail-
ability of biological or small molecule therapeutics to modulate
immune and inflammatory responses.
Materials and Methods
Isolation and culturing of EnCs and podocytes
Primary podocyte cultures (a gift from Prof. M.A. Saleem, University of
Bristol) and primary cultures of GEnCs (Cell Systems, Kirkland, WA)
were grown using EBM-2 medium (Lonza, Basel, Switzerland) as per the
suppliers’ directions. Conditionally immortalized cell lines of podocytes
developed from primary cultures by Prof. M.A. Saleem (42) and condi-
tionally immortalized GEnCs developed by Dr. S.C. Satchell (43) were
used in the experiments and maintained as described previously (44, 45).
Cells were grown to confluence at 33˚C (with 5% CO2) and left to dif-
ferentiate at 37˚C (with 5% CO2). Cell line podocytes differentiate in 14 d and
conditionally immortalized GEnCs differentiate in 24 h. Cell lines were tested
for their specific markers: GEnCs were stained for von Willebrand factor,
and podocytes were stained for Wilm’s tumor-1, nephrin, and podocin
(Supplemental Fig. 1). Human umbilical vein EnCs were isolated from fresh
umbilical cords with ethical approval, as described previously (46).
Neutrophil isolation
Human blood was collected from adult healthy volunteers with informed
consent into 10% acid citrate dextrose anticoagulant. Neutrophils were
isolated by Percoll discontinuous density gradient centrifugation (Amersham
Pharmacia Biotech, Little Chalfont, U.K.) as described previously (47).
Purity of neutrophils and cells were counted by microscopic inspection
and using a CASY technology cell counter.
Coculturing of EnCs on tissue culture inserts with or without
being in juxtaposition to podocytes
Podocytes and EnCs (GEnCs, both primary and differentiated conditionally
immortalized, and HUVECs) were harvested from confluent flasks and
suspended in RPMI 1640 medium. The cells were seeded at a density of
6 3 104 cells onto 3-mm porous polyethylene terephthalate transwell filter
inserts (BD Pharmingen, Oxford, U.K.). Podocytes were seeded on the
external surface of the transwell insert and allowed to adhere to the insert
for 4–6 h at 37˚C with occasional addition of medium. EnCs were seeded
inside of the insert (see Fig. 1A) and allowed to settle. Light microscopy
was used to determine the quality of the podocyte and EnC monolayers.
This was also confirmed with bisbenizimide staining following the adhe-
sion assay (see Fig. 1B). Monolayer integrity was assessed by measuring
the electrical resistance across podocyte monolayers (ranging between
0.7 and 1.1 V cm2), GEnCs (ranging between 5.7 and 11.2 V cm2), and
cocultured inserts (ranging between 10.2 and 16.3 V cm2) (n = 43)
(Supplemental Fig. 2). The inserts were placed in 24-well companion
plates after establishing the coculture and further cultured together for 24 h
at 37˚C (following procedures adapted from Refs. 13, 41, and 48). In
further studies to highlight the importance of juxtaposition of the cell
types, coculture was established without being in juxtaposition, where
GEnCs were seeded inside of the insert and podocytes were seeded in the
bottom of a 24-well companion plate (Fig. 1A) and conditioned for 24 h as
described earlier. Parallel monocultures of EnCs and podocytes were used
as comparators.
FIGURE 1. Illustration of the coculture system in the transwell. (A) Coculture of GEnCs and podocytes with or without being in juxtaposition. Podocytes
and GEnCs on the opposite side of the porous insert formed cocultures in juxtaposition. Cocultures without being in juxtaposition were formed allowing the
cell types to communicate through release of soluble mediators. Neutrophil recruitment was assessed to represent all cells that had bound to the GEnCs (i.e.,
firmly adherent and transmigrated). (B) Fluorescent micrographs showing neutrophil binding to and transmigration through GEnC/podocyte cocultures: (i)
Apical surface of transwell insert with neutrophils adherent to GEnCs in coculture, (ii) basal side of transwell insert with transmigrated neutrophils adjacent
to podocytes in coculture, (iii) apical surface of transwell insert with neutrophils adherent to GEnCs in monoculture, and (iv) basal side of transwell insert
with transmigrated neutrophils in GEnC monocultures. Original magnification 340.













The cultures were treated with a range of TNF-a (National Institute for
Biological Standards and Control, Potters Bar, U.K.) concentrations (0–
100 U/ml, unless otherwise stated) 4 h prior to the addition of neutrophils.
The concentration range and time period were taken from a previous study
(49). Nonadherent neutrophils and transmigrated cells were collected by
washing the GEnC/filter and the bottom of the well, respectively. Cells
were pooled with those obtained from washes and counted using a CASY
technology cell counter. The size-specific gating strategies were employed
to avoid counting of nonviable podocytes or GEnCs in supernatants. Ad-
herent neutrophils either located on the apical or basal surface of the filter
or adherent to the plate were fixed, stained with 2% isotonic glutaralde-
hyde with 1mg/ml bisbenzimide (both from Sigma-Aldrich, Gillingham,
U.K.), and analyzed using UV fluorescent microscopy and Image-Pro Plus
software (Media Cybernetics, Marlow, U.K.). Using the nuclear dye bis-
benzimide, the multilobed nuclei of neutrophils either on the apical or
basal surface of the insert were counted. These were distinguishable from
the mononuclear GEnCs or podocytes also in culture. Staining of the latter
also allowed confirmation of the integrity of the GEnC and podocyte mono-
layers. Percentage neutrophil recruitment was determined by summing
the counts from the filter, the lower supernatant and the plate (combin-
ing the adherent and total transmigrated neutrophils), in relationship to
the number of neutrophils added. All data were plotted as percentage
of recruited neutrophils of total added.
Detection of cytokines and CXC chemokines
Cell culture supernatants from cocultures or monocultures were screened
for cytokines and chemokines using a multiplex bead immunoassay
(Invitrogen, Paisley, U.K.) and Quantikine immunoassays (R&D Systems,
Abingdon, U.K.). Soluble IL-6 and CXC chemokines (CXCL8 and CXCL1)
were measured using the multiplex kit according to manufacturer’s instruc-
tions, and the data were expressed in picograms per milliliter calibrated
against standards.
Cell treatments
In some experiments, GEnC monocultures were treated with 10 ng/ml IL-6
(ImmunoTools, Arlette Luttmann, Germany) for 24 h prior to TNF-a
stimulation, and this was maintained throughout the experiment. Neu-
trophils were treated with blocking Abs against CXCR1 or CXCR2 indi-
vidually and in combination (both 4 mg/ml; IgG1) (clones 501 and 19,
respectively; BioSource International, Camarillo, CA) prior to their
recruitment on endothelial cultures. Concentrations were followed and
modified accordingly (50). To neutralize IL-6 activity, monoclonal anti–
IL-6 Ab (5 mg/ml, R&D Systems, clone 6708) was added to the medium
with the establishment of cocultures and maintained throughout the ex-
periment followed by 4 h TNF-a (100 U/ml) treatment (51). In defining the
molecules, which supported neutrophil migration, function-neutralizing
Abs against CXC chemokines CXCL1, CXCL5, and CXCL8 were used
at 2, 5, and 10 mg/ml respectively (all IgG1, clone 33160 against CXCL5,
clone 31716 against CXCL1, and clone 6217 against CXCL8; R&D
Systems, Abingdon, U.K.). Blocking Abs were added to the endothelium/
cultures for 24 h prior to the adhesion assay. Their effects were compared
with an isotype-matched mouse IgG1 mAb for all the experiments (Sigma-
Aldrich, Gillingham, U.K.) as the negative control. The concentrations of
the Abs had been established according to their detected levels using a
multiplexing bead immunoassay.
Knockdown of SOCS3 in GEnCs and podocytes
Cells were grown in RPMI 1640 with no antibiotics and subconfluent
GEnCs, and podocytes were transfected with 25 nM/l of three target-specific
commercial prevalidated SOCS3 small interfering RNAs or an appropriate
scrambled control (all Santa Cruz Biotechnology and Applied Biosystems,
Paisley, U.K.) or Lipofectamine alone in serum- and antibiotics-free Opti-
MEM medium (Life Technologies, Paisley, U.K.). The cells were trans-
fected using Lipofectamine (RNA iMAX, Invitrogen, Paisley, U.K.) reagent at
a final concentration of 0.3% (v/v) and incubated for 48 h at 37˚C in antibiotics-
free Opti-MEM medium. GEnCs and podocytes with SOCS knockdown were
trypsinized and either reseeded onto inserts for coculturing or used to prepare
cell lysates. SOCS3 knockdown in cell lysates was measured at the mRNA
level by real-time PCR and at the protein level by Western blotting to confirm
knockdown. Transfected podocytes were cocultured with transfected GEnCs,
as described previously, and were stimulated with TNF-a in coculture, and
functional assays were performed to determine the effect of knockdown.
Real-time PCR
For the detection of mRNAs for SOCS3, CXCL5, DARC, IL-6, and TNFR1,
total cellular RNA was isolated from TNF-a (100 U/ml)–stimulated cells
using an RNeasy Mini Kit 50 (Qiagen, Manchester, U.K.) following the
manufacturer’s protocol, and cDNA was generated using TaqMan reverse
transcription (Applied Biosystems, Carlsbad, CA). mRNA expressions
were quantified by using the commercially available primers from Applied
Biosystems, and the samples were amplified using the 7900 HT real-time
PCR machine and analyzed using the software package SDS 2.2 (Applied
Biosystems, Paisley, U.K.). Data were analyzed and expressed in com-
parison with GAPDH.
Western blotting
Whole-cell lysate was subjected to 10% SDS-PAGE, transferred onto ni-
trocellulose membrane (GE Healthcare, Little Chalfont, U.K.), and blotted
with primary Ab specific to SOCS3 (Abcam, Cambridge, U.K.). Blots were
then probed with appropriate HRP-conjugated anti rabbit secondary Ab
(Cell Signaling Technology, Hitchin, U.K.). Immunodetection was carried
out using the ECL Plus kit (GE Healthcare Life Sciences, Amersham Place,
U.K.) followed by exposure to x-ray film for 15 min.
Statistical analysis
Results are given as a percentage of recruitment neutrophils from the total
neutrophils added to the system. Data were assessed as being parametric or
nonparametric prior to the use of an appropriate statistical test. Variation
between multiple treatments was evaluated using an ANOVA or a Friedman
test, followed by Bonferroni or Dunnett post hoc multiple comparison tests
FIGURE 2. Recruitment of neutrophil to TNF-a–treated GEnC mono-
and cocultures. (A) Primary or (B) immortalized cell line cultures of
GEnCs and podocytes were cultured in juxtaposition (open bars) and
stimulated with TNF-a (0-100 U/ml). GEnC monocultures (filled bars)
were assessed as controls. Neutrophils were allowed to adhere and migrate
through the constructs. Neutrophil recruitment was assessed at 1 h and
taken to represent all cells that had bound to the GEnCs (i.e., firmly ad-
herent [hashed bars] and transmigrated [plain bars]). Data are means 6
SEM. (A) n = 4 and (B) n = 11–32. **p , 0.01, ***p , 0.0001 for the
effect of cytokine treatment as determined by a paired Wilcoxon signed-
rank test between treatments within cultures. dp , 0.05, dddp , 0.0001
for difference between cocultures and monocultures as determined by
a Mann–Whitney U test.













as appropriate. Variations were also analyzed by a paired t test, an unpaired
t test, and a Mann–Whitney U test. A p value of ,0.05 was considered
significant. All the data were analyzed using Prism (GraphPad Prism
Software, San Diego, CA).
Results
The effect of podocytes on the recruitment of neutrophils to
cocultured endothelial cells
The effect of podocytes on the ability of endothelium to support
neutrophil recruitment was examined in the presence of an in-
flammatory stimulus. In a static adhesion assay, GEnCs were
cultured adjacent to podocytes (either primary or conditionally
immortalized) on apical and basal surfaces of a porous filter in
juxtaposition for 24 h (Fig. 1). Cocultures supported neutrophil
recruitment in a TNF-a dose–dependent manner, with most
recruited cells undergoing transendothelial migration (Fig. 2).
Importantly, the level of neutrophil recruitment by GEnCs
cocultured in juxtaposition to podocytes was significantly lower
(by up to 50%) at 100 U/ml TNF-a (high dose) when compared
with GEnC monocultures (Fig. 2). Similar observations were
made using primary (Fig. 2A) and immortalized cells (both en-
dothelial and podocytes) in coculture (Fig. 2B). All further
experiments were performed using immortalized cell lines, as
these could support the inhibitory effects of coculture and were
considerably easier to acquire and coculture.
In comparison, when HUVECs were cocultured with podocytes,
the reduction in neutrophil recruitment was not observed (Table I).
Thus, podocytes appear to regulate inflammatory responses me-
diated by GEnCs in a tissue-specific manner.
Role of soluble mediators released in cocultures on neutrophil
recruitment
Next we investigated the role of soluble mediators in regulating
the inflammatory response of cocultured GEnCs. To address this,
we cultured GEnCs on a transwell filter above podocytes cultured
in the bottom of the culture dish, thus separating each cell type
(Fig. 1B). In this format, neutrophil recruitment was significantly
reduced compared with a monoculture of GEnCs (Fig. 3), indi-
cating that the altered neutrophil recruitment was at least partially
dependent on a soluble mediator. As expected, when HUVECs
were cultured in this format there was no significant alteration in
the behavior of neutrophils (Table I).
IL-6 mediates the anti-inflammatory crosstalk between
podocytes and GEnCs
To identify the specific soluble mediators responsible for the
inhibition in neutrophil recruitment we compared supernatants
generated from GEnCs under conditions of monoculture or during
coculture with podocytes. Multiplex ELISA showed low levels of
IL-6 in supernatants from GEnC monocultures treated with or
without exogenous TNF-a (Fig. 4A). Alternatively, TNF-a–
stimulated podocyte monocultures and GEnC/podocyte cocultures
released significantly higher levels of IL-6 compared with unsti-
mulated cultures (Fig. 4A). In contrast, HUVECs suppressed
podocyte production of IL-6 during coculture (Supplemental Fig.
3), possibly explaining why we observed no inhibition of neu-
trophil recruitment in these constructs. These data strongly sug-
gests that IL-6 generated in GEnCs/podocytes in cocultures was
primarily released by podocytes.
We have previously reported that IL-6 produced during endo-
thelial–dermal fibroblast coculture suppresses cytokine-induced
lymphocyte recruitment (51). Thus, we considered whether IL-6
may be playing a similar role in the present study. When the bi-
ological activity of IL-6 was removed from coculture supernatants
using a function neutralizing Ab, the inhibitory effects of cocul-
ture were lost (Fig. 4B). Moreover, treating GEnC monocultures
with exogenous IL-6 (10 ng/ml, equivalent to the levels released in
coculture) significantly reduced neutrophil recruitment (Fig. 4C).
These results demonstrate that IL-6 is key mediator in the anti-
inflammatory crosstalk that regulates neutrophil recruitment in
cocultures of GEnCs and podocytes.




HUVECs in monocultures 4.9 6 1.5 15.7 6 0.8* 24.57 6 3.01**
HUVECs in direct contact with podocytes 11.43 6 4.7 21.53 6 5.7 38.7 6 9.8*
HUVECs with no direct contact 5.7 6 1.13 14.5 6 1.9* 24.01 6 1.6**
HUVECs and podocytes were seeded in juxtaposition on opposite sides of a porous insert, prior to stimulation with
increasing concentrations of TNF-a (0–100 U/ml). HUVEC monocultures were assessed as controls. Neutrophils were
allowed to adhere and migrate through the constructs. Neutrophil recruitment was assessed at 1 h and taken to represent
all cells that had bound to the HUVECs (i.e., firmly adherent and transmigrated). Data are means 6 SEM. n = 3 expressed as
percentage of neutrophil recruitment of total added neutrophils.
Friedman test shows a significant effect of cytokine treatments on neutrophil recruitment (p, 0.001), *p, 0.05, **p, 0.001,
compared with untreated within individual cultures by a Dunnett post hoc test.
FIGURE 3. Role of soluble mediators in regulating neutrophil recruit-
ment to GEnCs. GEnCs were seeded onto the apical surface (i.e., inside)
a porous filter. Podocytes were seeded onto the bottom of the well.
Cocultures were formed by placing the GEnC-coated filter above the
podocyte-coated well, allowing the cell types to communicate through
release of soluble mediators. Cytokine-induced neutrophil recruitment
was assessed at 1 h. Data are means 6 SEM (n = 4). A Friedman test
shows a significant effect of cytokine treatments on neutrophil recruitment
(p , 0.001). *p , 0.05 comparing the effects of TNF-a treatment to
untreated cultures by a Dunnett post hoc test, dp , 0.05 comparing
cocultures (open bars representing cocultures) to monocultures (filled bars)
by an unpaired t test.













SOCS3 is important for IL-6–mediated regulation of neutrophil
recruitment in cocultures
SOCS3 belongs to a family of cytokine-inducible SH2 proteins that
are shown to be involved in the negative regulation of cytokine
signaling involving JAKs and STATactivity. Importantly, SOCS3 is
known to be involved in blocking the downstream signaling from
the IL-6 receptor (reviewed in Ref. 52). In this study, we used three
small interfering RNA oligomers in combination or individually to
knockout SOCS3 expression in both GEnCs and podocytes prior
to coculture. Successful knockdown of SOCS3 was confirmed by
quantitative real-time PCR analysis (Fig. 5A) and Western blotting
(Fig. 5B), and it was unaffected by the presence of scrambled
control. Inhibition of SOCS3 expression in podocytes and GEnCs
simultaneously or GEnCs alone in coculture released neutrophils
from the inhibitory effects of coculture (Fig. 5C). Interestingly,
however, the loss of SOCS3 in podocytes alone had no significant
effect on neutrophil recruitment to the cocultured cells. These
observations indicated that SOCS3 signaling in GEnCs is crucial
in cocultures and that IL-6 may regulate the function of both cell
types simultaneously.
The role of CXC chemokines and their receptors in neutrophil
recruitment to cocultures
The CXCR1, CXCR2, and their CXC chemokine ligands are
recognized as key mediators in neutrophil recruitment (53). In the
present study, we performed blocking studies to elucidate the role
of these molecules in our own assays. In agreement with previous
publications (50), both CXCR1 and CXCR2 played a role in
supporting neutrophil migration across TNF-a–treated GEnC
monocultures (Fig. 6). Importantly, however, only CXCR2 inter-
actions were required for neutrophil recruitment to coculture
GEnCs (Fig. 6). Blocking both receptors in combination further
reduced neutrophil migration in both mono- and cocultures
(to ,5%) when compared with blocking each receptor indi-
vidually (Fig. 6).
To confirm which chemokines were involved, we examined the
expression of the CXCL5 (epithelial neutrophil–activating peptide
78), CXCL8 (IL-8), and CXCL1 (growth-related oncogene a) in
culture supernatants. There was a significant increase in the levels
of all analytes in coculture supernatants compared with GEnCs in
monoculture (Fig. 7). Thus, to determine which of these were
functionally relevant we blocked their activity with neutralizing
Abs. Importantly, only CXCL5 blockade significantly reduced
neutrophil recruitment to cocultured GEnCs (Fig. 8). Thus, in this
coculture model of the human, glomerulus neutrophil trafficking
appears to be regulated through the activation of CXCR2 by
CXCL5. Interestingly, this is a pattern of activity we have ob-
served in another assay system using endothelial cells cocultured
with fibroblasts from the rheumatoid joint. In the arthritis model
CXCL5 was preferentially deposited on the EnC surface by the
action of the DARC (54), even though other CXC ligands were
present at greater concentrations.
FIGURE 4. Role for IL-6 in negative regulation of neutrophil recruit-
ment in cocultures. (A) Detection of IL-6 in supernatants of GEnC and
podocyte cocultures (▴) and monocultures of GEnC (n) and podocytes (d)
that were treated with and without TNF-a. Data are means6 SEM (n = 4).
Two-way ANOVA shows a significant effect of cytokine treatment on IL-6
production (p , 0.05). *p , 0.05 comparing IL-6 production between
cocultures and GEnC monocultures by a Bonferroni post hoc test. (B)
Neutralization of IL-6 in cultures by incorporation of 5 mg/ml anti–IL-6
Ab (labeled as IL-6 block) into TNF-a (100 U/ml)–stimulated cultures for
24 h starting from the time of establishing the cocultures. Neutrophil re-
cruitment was assessed at 1 h and is expressed as percentage of cells
recruited. Data are represented as minimum to maximum levels of re-
cruitment (n = 5). The effects were compared with an isotype-matched
mouse IgG in these experiments. *p , 0.05, **p , 0.001 comparing the
effect of IL-6 neutralization with controls by a paired t test. (C) Recapit-
ulation of coculture by addition of exogenous IL-6 in GEnC monocultures
(n = 4). *p , 0.05 by Mann–Whitney U test when comparing treatments,
***p , 0.0001 comparing the effect of cytokine treatment by a paired
Wilcoxon signed-rank test between treatments within cultures, ***p ,
0.0001 comparing the effect of cytokine treatment by a paired Wilcoxon
signed rank test between treatments within cultures.













SOCS3 knockdown upregulates the expression of inflammatory
genes
Because deletion of SOCS3 has been shown to prolong activation of
STAT1 and STAT3 following IL-6 stimulation, thereby enhancing
inflammatory responses (54–56), we wondered whether a similar
mechanism was operating in our cocultures. Specifically, we were
interested in changes in the key regulators of neutrophil trafficking
that we had identified above, and thus we examined the gene
expression of CXCL1, CXCL5, CXL8, DARC, and TNFR1 in
GEnCs or podocytes before and after SOCS3 knockdown. In the
absence of SOCS3, CXCL5 and DARC were upregulated in
GEnCs from cocultures (Fig. 9A and 9B, respectively), whereas
CXCL1 and CXCL8 expression were unaffected (data not shown).
Furthermore, we also detected upregulated expression of IL-6 in
podocytes from cocultures and TNFR expression in both GEnCs
and podocytes from cocultures upon knockdown of SOCS3
(Fig. 9C and 9D, respectively). Taken together, these results imply
that IL-6–induced SOCS3 signaling has anti-inflammatory effects
by downregulating the expression of TNFR on both of the
cocultured cells, but also by reducing the expression of the CXC
chemokine (CXCL5) despite it being the dominant chemokine
released in supernatants from cocultures, and it thus regulates
neutrophil trafficking. Additionally, reducing the expression of
DARC may decrease the efficiency with which CXCL5 is trans-
located and expressed on the surface of cocultured endothelial
cells, enabling proper presentation of CXCL5 on the surface of
GEnCs in cocultures. These results also support the previous ev-
idence that SOCS3 negatively regulates IL-6 signaling and coor-
dinates appropriate cytokine-mediated biological responses, and
they suggest a unique regulatory mechanism to control neutrophil
recruitment in glomeruli under homeostasis.
Discussion
In glomeruli, the maintenance of vascular endothelial functions
depends on the crosstalk with closely apposed podocytes and
GEnCs. The purpose of this study was to reconstruct the glomerular
environment to determine whether such crosstalk was an important
arbiter of the recruitment of neutrophils during inflammation.
The processes of leukocyte recruitment (adhesion and migra-
tion) have been elucidated in vitro using isolated leukocytes and
cultured EnCs, with supporting evidence from intravital models of
FIGURE 5. SOCS3-mediated downregulation of neutrophil recruitment
in cocultures of GEnCs and podocytes. (A) Detection of SOCS3 mRNA in
TNF-a (100 U/ml)–stimulated cultures of GEnCs (filled bars) and podocytes
(open bars) by quantitative PCR following SOCS3 knockdown with three dif-
ferent oligomers (labeled A [mixture of three oligomers] and B and C [indi-
vidual oligomers]) or a scrambled control. Lipofectamine presence is indicated,
whereas “untreated” indicates absence of Lipofectamine, scrambled control, or
SOCS oligomers. Data are minimum to maximum (n = 3–6). A Friedman test
compared the effect of SOCS3 knockdown (p , 0.05). *p , 0.05 comparing
controls within cultures by a Dunnett post hoc test. (B) Western blotting con-
firming the SOCS3 protein knockdown in GEnCs and podocytes compared with
controls (untreated cultures, Lipofectimine-treated cultures, and scrambled RNA-
treated cultures). b-actin was used as loading control. (C) Neutrophil recruitment
in cocultures (open bars) and GEnC monoculture (filled bars) with SOCS3
knockdown (2/2) with three different oligomers (labeled A [mixture of three
oligomers] and B and C [individual oligomers]) or a scrambled control. Lip-
ofectamine presence is indicated, whereas “untreated” indicates absence of
Lipofectamine, scrambled control, or SOCS oligomers. Neutrophil recruitment
in cocultures was also tested with SOCS3 knockdown in only one cell type.
Neutrophil recruitment was assessed in TNF-a (100 U/ml)–treated cultures at
1 h. Data are minimum to maximum of recruited cells (n = 3–7). A Friedman
test compared the effect of SOCS3 knockdown (p , 0.05). *p , 0.05, **p ,
0.01 comparing with controls by a Dunnett post hoc test.
FIGURE 6. Role of CXC receptors in supporting neutrophil migration.
CXCR1 and CXCR2 receptors were blocked either individually or in
combination using respective blocking Abs (4 mg/ml) on neutrophils for
15 min prior to addition in both GEnC monocultures (filled bars) and
cocultures (open bars) stimulated with TNF-a (100 U/ml). Neutrophil
recruitment was assessed at 1 h and expressed as percentage of added cells.
The effects were also compared with an isotype-matched mouse IgG in
these experiments. Data are means 6 SEM (n = 5). ANOVA shows a sig-
nificant effect of treatment on neutrophil migration (p , 0.05). *p , 0.05,
**p , 0.01, ***p , 0.0001 comparing the effect of receptor blocking on
neutrophil migration with their respective controls within cultures by
a Bonferroni post hoc test. Untreated, absence of isotype control Ab,
CXCR1, and anti-CXCR2 blocking Abs.













inflammation (55–58). However, in vivo validation has been im-
portant, because the behavior of EnCs is influenced by stromal
cells and soluble mediators released in their local environment.
Thus, to reflect the in vivo situation more precisely in vitro, it is
necessary to develop integrated multicellular models that better
reflect the inflammatory environment. In the present study we
developed an experimental model of the glomerulus to mimic the
context of acute inflammation in a tissue-specific manner. Mono-
layers of GEnCs and podocytes were cultured together, separated by
a semipermeable membrane, allowing us to study how the inter-
actions between these two cell types influenced the recruitment of
neutrophils during inflammation.
A key observation was that the presence of podocytes signifi-
cantly reduced the ability of inflamed endothelium to support
neutrophil recruitment. This regulatory phenomenon was observed
with varying potency across a range of TNF-a concentrations,
indicating that podocytes are capable of modifying the responses
of GEnCs to TNF-a. Podocytes exerted their anti-inflammatory
effects both in the presence and absence of close proximity with
the endothelium, strongly suggesting the influence of a soluble
mediator. Moreover, TNF-a upregulated IL-6 release by podo-
cytes in coculture with GEnCs, and neutralizing IL-6 reversed the
observed reduction of neutrophil binding. Importantly, addition of
exogenous IL-6 to GEnC monocultures recapitulated the reduction
in neutrophil recruitment observed in cocultures. This demon-
strates that IL-6 can act in an anti-inflammatory manner to regu-
late neutrophil recruitment in the glomerular environment.
Interestingly, HUVECs cocultured with podocytes were unable to
suppress neutrophil binding. Indeed, HUVECs downregulated IL-6
release in podocytes. Collectively, these observations indicate that
podocytes communicate with GEnCs in a tissue-specific manner
through the medium of IL-6 secretion and are capable of influencing
endothelial responses through a range of inflammatory states.
FIGURE 7. Detection of CXCL1, CXCL5, and CXCL8 in cocultures
and monocultures. Detection of soluble (A) CXCL1, (B) CXCL5, and (C)
CXCL8 in supernatants collected from TNF-a–stimulated cocultures (d),
GEnC monocultures (n), and podocyte monocultures (▴). Data expressed
as means 6 SEM (n = 3). *p , 0.05, **p , 0.01, ***p , 0.0001 com-
paring the difference in chemokine expression between cocultures and
GEnC monocultures by two-way ANOVA.
FIGURE 8. Neutralization of CXCL1, CXCL5, and CXCL8 in cocul-
tures and monocultures. Cultures were treated with function neutralizing
Abs against (A) CXCL1 (2 mg/ml), (B) CXCL5 (5 mg/ml), and (C) CXCL8
(10 mg/ml) for 24 h prior to addition of neutrophils. Data are means 6
SEM (n = 5–6). *p , 0.05, **p , 0.01, ***p , 0.0001 comparing the
effect of blocking chemokine function in cultures with their controls by
a paired t test.













Podocytes are a known source of IL-6 that could play a critical
role in modulation of progressive glomerular disease (31, 37, 59).
Previous in vivo and in vitro studies have demonstrated the role for
IL-6 in attenuation of LPS-induced effects on neutrophil infiltra-
tion, and IL-6 also suppressed the response of inflammatory
cytokines in a number of models (37, 40, 60–62). Interestingly,
these models exhibited reduced, as well as enhanced, leukocyte
adhesion to EnCs depending on the nature of the stromal cells
with which they were cocultured (12, 51).
The later part of our study establishes the mechanisms under-
pinning the IL-6–mediated inhibition of TNF-a–mediated in-
flammatory responses in cocultures. Our observations demonstrate
an upregulation of SOCS3, which obstructed the IL-6 signaling
pathway, and we further demonstrated that SOCS3 depletion in
both GEnCs and podocytes or GEnCs alone in cocultures resulted
in increased neutrophil recruitment in TNF-a–stimulated cocul-
tures. Indeed, previous studies have demonstrated a role for
SOCS3 in human IL-6–mediated regulation of neutrophil adhe-
sion (63). IL-6 can induce rapid induction of SOCS gene tran-
scription, including SOCS3, suggesting a role for SOCS in
a negative feedback loop regulating IL-6 signal transduction.
Moreover, SOCS3 deficiency can have deleterious effects allowing
prolonged activation of STAT1 and STAT3 after IL-6 stimulation,
and it was shown to promote the expression of IFN-inducible
genes (64–66). Loss of SOCS3 activity also led to enhanced
production of G-CSF and IL-6 in a mouse model of inflamma-
tory arthritis (67, 68). Similarly, our studies further demonstrate
that SOCS3-deleted cells from cocultures show upregulated
expression of inflammatory genes such as TNFR1 and IL-6 in
podocytes and elevated levels of CXCL5 and TNFR1 expression
in GEnCs that supported increased neutrophil recruitment in
SOCS3 knocked down cocultures. Similar mechanisms could be
involved in GEnC with exogenous IL-6 in cultures; however, these
mechanisms have not yet been identified. Collectively, available
evidence suggests that upregulation of SOCS3 by IL-6 can sup-
press IL-6 signaling via negative feedback loops and that deletion
of SOCS3 upregulates the expression of inflammatory genes in the
GEnC and podocyte cocultures.
Furthermore, the mechanism involved in efficient migration of
minimally recruited neutrophils in cocultures was analyzed. The
residual neutrophil recruitment to the cocultures appeared to be
more efficient at migrating through the membrane, indicating
a potential role for chemokines and their receptors. Neutrophil
chemokine receptors (CXCR1 and CXCR2) were shown to have
key role in transmigration across TNF-a–treated GEnC mono-
cultures, in agreement with previous findings (50). Interestingly, in
cocultures, blockade of CXCR2 on neutrophils was sufficient
to reduce the residual neutrophil migration in cocultures, and dou-
ble blocking strongly indicates the nonredundant role for CXC
receptors in supporting the neutrophil migration in our cultures.
The CXCR2 role in cocultures suggests the possible involvement
of chemokines other than CXCL8, because CXCR2 binds multiple
ELR chemokines (44, 45, 69). Importantly, CXCR1 binds to
ligands CXCL8 and CXCL6 with high affinity, whereas CXCR2 is
more promiscuous and binds CXCL1, CXCL2, CXCL3, CXCL5,
CXCL6, CXCL7, and CXCL8 (44, 45, 69). Supernatant analysis
demonstrated a prominent increase in soluble CXCL1, CXCL5,
and CXCL8 in monocultures and cocultures, and blocking these
molecules on GEnCs revealed a role for these chemokines, to
varying degrees, in supporting neutrophil recruitment in glomer-
ular cocultures. In GEnC/podocyte cocultures, CXCL5–CXCR2
interactions seem to be playing a dominant role, because blocking
FIGURE 9. Effect of SOCS3 deletion in the upregulation of genes that support neutrophil recruitment in cocultures. Quantification of expression of genes
(A) CXCL5, (B) DARC, (C) IL-6, and (D) TNFR1 that supported the neutrophil recruitment in cocultures, prior to and after depletion of SOCS3, in GEnCs
and podocytes from mono- and cocultures compared with monocultures without SOCS3 knockdown. Data are expressed as fold change to TNF-a–
stimulated monocultures (n = 5). *p , 0.05, **p , 0.01, ***p , 0.0001 comparing the difference in gene expression with the stimulated monocultures
without SOCS3 knockdown by an unpaired t test.













CXCL5 activity but not CXCL8 or CXCL1 significantly reduced
the residual neutrophil recruitment in cocultures. This suggests
selective presentation of CXCL5 on GEnC surfaces in cocultures.
In this regard, previous studies using multicellular constructs from
our group and others have reported that DARC presents CXCL5
on the endothelial surface, triggering integrin activation and sta-
bilization of adherent leukocytes (14, 54, 70). Moreover, the level
of DARC expression on the endothelium has been shown to
facilitate chemokine-mediated leukocyte trafficking (70, 71). In
the present study, we observed a SOCS3-dependent reduction in
DARC gene expression in cocultured GEnCs. Appropriate che-
mokine presentation is required for stabilizing neutrophil adhesion,
and in further support of endothelial transmigration, a deficiency in
this process accounted for the reduction in neutrophil recruitment in
our coculture. Furthermore, CXCL5 binding to DARC has been
reported to regulate the availability of other chemoattractants such
as CXCL1 and CXCL2 (71, 72). DARC knockout mice were pro-
tected from postischemic acute renal failure owing to impaired
renal neutrophil recruitment and disruption in endothelial chemo-
kine presentation (73–75). Importantly, specificity of chemokines is
involved in IL-6–mediated signaling, an observation that is analo-
gous to our findings in a coculture model of the glomerulus.
Interestingly, the presently reported reduction of neutrophil
recruitment may be specific to GEnCs because the podocyte-
mediated reduction of neutrophil recruitment was not observed
in the cocultures of HUVECs and podocytes. The regulation
of neutrophil recruitment may have been absent from HUVEC
cocultures owing to lower levels of IL-6 release (Supplemental
Fig. 3), suggesting that HUVECs may actually downregulate IL-6
production from podocytes. Our previous studies have shown that
exogenous IL-6 can reduce the ability of HUVECs to respond
tocytokine stimulation as measured by their ability to capture
lymphocytes (51) or neutrophils from flow (76). Moreover, addi-
tion of soluble IL-6Ra in conjunction with IL-6 has been shown to
be required to induce adhesion of neutrophils to EnCs (77).
Thus, IL-6–dependent cellular crosstalk, capable of modulating
endothelial activation and leukocyte adhesion, may be defined by
the exact milieu (41). However, the balance shifts with magnitude
and duration of response, leading to inflammation and disease, as
seen in rheumatoid arthritis (78), and conceivably this balance
could also change unfavorably during some glomerular diseases.
In conclusion, the present studies reveal that podocytes play a role
in the modulation of neutrophil recruitment to GEnCs by releasing
IL-6, which, in turn, initiates negative feedback loops with upregu-
lation of SOCS3. Although SOCS3 seems to be the dominant mol-
ecule in this podocyte-mediated regulatory process, the subsequent
anti-inflammatory pathways have not been defined in this model,
and by analogy with other systems, inhibition of STAT signaling may
occur. These observations highlight the anti-inflammatory paracrine
and autocrine actions of podocyte-derived IL-6. It is conceivable that
these favorable effects of IL-6 may be modified during severe or
prolonged episodes of glomerular inflammation. Additionally, the
present observations add a note of caution regarding the possibility of
worsening renal inflammation by therapies that target IL-6.
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